NORTHBROOK, Ill., Aug. 3, 2023/PRNewswire/ — Bridge to Life Ltd. (BTL), a leading global provider of organ preservation and perfusion technologies, today announced the sale of certain assets to TransMedics, Inc., a wholly owned subsidiary of TransMedics Group, Inc. (NASDAQ: TMDX), which includes its cardiac and lung perfusion assets EVOSS and LifeCradle. BTL will use the proceeds from the sale of these assets to focus on its core business of preservation solutions and its pending submission to the Food and Drug Administration (FDA) for the VitaSmart™ Liver Machine Perfusion System.
Commenting on the transaction, BTL CEO Don Webber explained: “This transaction allows us to strengthen our financial position and adequately fund the continued expansion of our leading share of the global preservation solutions market, as well as continue the development of our VitaSmart abdominal organ perfusion device.In May 2023, we announced completion of enrollment for our pivotal HOPE trial, and we expect to submit our application for premarket approval to the Food and Drug Administration by the end of this anus”. https://bridgetolife.com/early-closure-of-bridge-to-life-ltd-hope-liver-trial-enrollment-affirms-the-potential-of-hypothermic-oxygenated-perfusion/
Piper Sandler
For over a decade, Bridge to Life Ltd. has set the standard of care by providing the gold standard Belzer UW® preserving solutions along with other leading products, including EasiSlush®, to the transplant community. The company also recently announced promising interim results from the pivotal study for its VitaSmart™ liver perfusion device and completed enrollment in the Bridge to HOPE liver clinical trial well ahead of schedule. The company is setting a new standard in hypothermic oxygenated machine perfusion with the unique HOPE protocol developed with leading international organ transplant surgeons. Through the development of highly effective and sustainable technologies, Bridge to Life remains steadfast in its ongoing mission to alleviate organ transplant waiting lists by ensuring equitable access to these innovative new technologies for all patients.
Logo – https://mma.prnewswire.com/media/2085277/Bridge_to_Life_Logo.jpg
View original content: https://www.prnewswire.com/news-releases/bridge-to-life-vende-ciertos-activos-a-transmedics-301892857.html
